Free Trial

Clene (CLNNW) Competitors

$0.03 0.00 (-4.00%)
As of 06/13/2025 03:55 PM Eastern

CLNNW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Clene stock or one of its competitors? The main competitors of Clene include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Clene vs. Its Competitors

Clene (NASDAQ:CLNNW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, community ranking, valuation, analyst recommendations, media sentiment and institutional ownership.

Company Net Margins Return on Equity Return on Assets
CleneN/A N/A N/A
180 Life Sciences N/A N/A N/A

Clene and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CleneN/AN/A
180 Life SciencesN/AN/A

In the previous week, Clene and Clene both had 1 articles in the media. Clene's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that Clene is being referred to more favorably in the media.

Company Overall Sentiment
Clene Very Positive
180 Life Sciences Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clene$350KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Clene beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks.

Get Clene News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLNNW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLNNW vs. The Competition

MetricCleneBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$124.74M$5.56B$8.50B
Dividend YieldN/A3.74%5.28%4.16%
P/E RatioN/A3.2526.6419.64
Price / SalesN/A4,108.15407.99152.17
Price / CashN/A13.1938.2534.64
Price / BookN/A35.866.974.60
Net IncomeN/A-$91.56M$3.23B$248.06M
7 Day PerformanceN/A0.34%-1.05%-0.87%
1 Month PerformanceN/A6.24%8.66%3.58%
1 Year PerformanceN/A180.83%33.67%14.04%

Clene Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLNNW
Clene
N/A$0.03
-4.0%
N/A-25.7%$0.00$350K0.00100Positive News
Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-10.5%
N/A-38.0%$0.00N/A0.007Positive News
Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+53.1%
N/AN/A$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.11
-4.1%
N/A+118.3%$0.00$106.21K0.0040
ALVOW
Alvotech
N/A$2.58
+3.6%
N/A-41.6%$0.00$585.60M0.004
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
-16.5%
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.09
+0.2%
N/A+136.9%$0.00$38.00M0.0070
BTMDW
biote
N/A$0.02
+10.0%
N/A-94.4%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.08
+19.6%
N/A-80.0%$0.00N/A0.008Positive News
Short Interest ↑
CELUW
Celularity
N/A$0.05
+24.8%
N/A+118.3%$0.00$54.22M0.00220Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:CLNNW) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners